Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer;Cardiovascular;Adverse Events”

276 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 276 results

Not applicableNot Yet RecruitingNCT06897189
What this trial is testing

Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study

Who this might be right for
CardiotoxicityThoracic RadiotherapyWearable Electronic Devices+2 more
Yonsei University 111
Not applicableLooking for participantsNCT06726590
What this trial is testing

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Who this might be right for
DiabetesCholesterolCancer+6 more
Texas A&M University 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT03934905
What this trial is testing

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Who this might be right for
Anthracycline Related Cardiotoxicity in Breast Cancer
Texas Tech University Health Sciences Center 70
Not applicableStudy completedNCT05403736
What this trial is testing

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Who this might be right for
Cancer
Cedars-Sinai Medical Center 20
Not applicableUnknownNCT06409481
What this trial is testing

Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)

Who this might be right for
Cardiovascular DiseasesCardiac DiseasesVascular Diseases+1 more
The First Affiliated Hospital of Xinxiang Medical College 800,000
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Large-scale testing (Phase 3)Study completedNCT05605964
What this trial is testing

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

Who this might be right for
Prostate Cancer
Sumitomo Pharma America, Inc. 387
Not applicableUnknownNCT04961307
What this trial is testing

Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab

Who this might be right for
CardiotoxicityAntitumor DrugsBreast Cancer+1 more
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07654426
What this trial is testing

The CARDIOPROTECT Trial

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)CardiotoxicityLymphoma
Beth Israel Deaconess Medical Center 60
Not applicableStudy completedNCT03243604
What this trial is testing

CARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study

Who this might be right for
Arrhythmias, CardiacAtrial Fibrillation and FlutterTachycardia, Supraventricular+1 more
Groupe Hospitalier Pitie-Salpetriere 1,717
Not applicableActive Not RecruitingNCT05036252
What this trial is testing

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Who this might be right for
Breast CancerHER2-positive Breast CancerHER2-positive Metastatic Breast Cancer+5 more
Memorial Sloan Kettering Cancer Center 23
Not applicableStudy completedNCT03530215
What this trial is testing

Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)

Who this might be right for
Cardiac DiseaseCancer
Groupe Hospitalier Pitie-Salpetriere 500,000
Not applicableNot Yet RecruitingNCT06595316
What this trial is testing

Exercise for Ameliorating Chemotherapy Cardiotoxicity

Who this might be right for
Cardiotoxicity
University of Hull 30
Not applicableUnknownNCT02942615
What this trial is testing

The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.

Who this might be right for
Breast NeoplasmsCardiotoxicity
Ruijin Hospital 220
Early research (Phase 1)Active Not RecruitingNCT06223516
What this trial is testing

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 60
Not applicableNot Yet RecruitingNCT03969693
What this trial is testing

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

Who this might be right for
Mediastinal LymphomaHodgkin LymphomaNon Hodgkin Lymphoma
Chang Gung Memorial Hospital 50
Not applicableNot Yet RecruitingNCT05377320
What this trial is testing

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Who this might be right for
Heart FailureCoronary Artery DiseasePeripheral Artery Disease+5 more
Medical College of Wisconsin 60
Not applicableLooking for participantsNCT03882580
What this trial is testing

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

Who this might be right for
Cardiovascular ComplicationCardiovascular InsufficiencyCardiac Complication+5 more
Groupe Hospitalier Pitie-Salpetriere 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT06892522
What this trial is testing

Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

Who this might be right for
Multiple Myeloma
AbbVie 602
Not applicableLooking for participantsNCT04822077
What this trial is testing

Study on Proton Radiotherapy of Thymic Malignancies

Who this might be right for
CardiotoxicityPulmonary ToxicityThymus Neoplasms
Ass. Prof. Jan Nyman 40
Next Page